MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/jog.15718

Медицинская библиотека · The journal of obstetrics and gynaecology research · 2023

Primordial follicles remaining in young cancer survivors who received chemotherapy.

Ogino Nana, Wakimoto Yu, Nakagawa Kohei, Kamei Hidetake, Fukui Atsushi, Yoshiyasu Kanako, Hasegawa Akiko, Hirota Seiichi, Shibahara Hiroaki

СтатьяПеревод пока не подготовлен

Аннотация

AIM: Ovarian tissue cryopreservation (OTC) is performed for fertility preservation in cancer patients undergoing chemotherapy. Although anti-Müllerian hormone is used as a marker for ovarian reserve, serum levels do not always correlate with the number of follicles. Additionally, the follicle development stage most affected by chemotherapy is unclear. We examined the association between serum anti-Müllerian hormone levels and the number of remaining primordial follicles after chemotherapy, as well as which follicle stage is most affected by chemotherapy before ovarian cryopreservation.

METHODS

Thirty-three patients who underwent OTC were divided into the chemotherapy (n = 22) and non-chemotherapy (n = 11) groups; their ovarian tissues underwent histological examination. Pathological ovarian damage induced by chemotherapy was assessed. Ovarian volumes were estimated from weights. We compared the number of follicles at each developmental stage as a percentage of primordial follicles between the groups. The relationship between serum anti-Müllerian hormone level and primordial follicle density was analyzed.

RESULTS

The chemotherapy group had a significantly lower serum anti-Müllerian hormone level, ovarian volume, and density of developing follicles than the non-chemotherapy group. Serum anti-Müllerian hormone levels correlated with primordial follicle density only in the non-chemotherapy group. The chemotherapy group had significantly lower numbers of primary and secondary follicles.

CONCLUSIONS

Chemotherapy induces ovarian damage and follicle loss. However, serum anti-Müllerian hormone level does not always reflect the number of primordial follicles after chemotherapy, and chemotherapy more significantly affects primary and secondary follicles than primordial follicles. Many primordial follicles remain in the ovary after chemotherapy, supporting OTC for fertility preservation.

Для цитирования: Ogino Nana, Wakimoto Yu, Nakagawa Kohei, Kamei Hidetake, Fukui Atsushi, Yoshiyasu Kanako, Hasegawa Akiko, Hirota Seiichi, Shibahara Hiroaki. Primordial follicles remaining in young cancer survivors who received chemotherapy.. The journal of obstetrics and gynaecology research. 2023. DOI: 10.1111/jog.15718.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.